Skip to main content
Clinical Trials/NCT05182528
NCT05182528
Unknown
Not Applicable

Hematological Disorders in Covid 19 Patients

Assiut University0 sites200 target enrollmentJanuary 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hematological Abnormalities in covid19
Sponsor
Assiut University
Enrollment
200
Primary Endpoint
Hematological disorders in covid 19 patients
Last Updated
4 years ago

Overview

Brief Summary

aim of the research is to detect hematological abnormalities in covid 19 patients and its correlation with the severity and outcome of the disease.

Detailed Description

Covid 19 is an infectious disease caused by a newly discovered coronavirus.most people infected with the covid 19 virus will have mild to moderate respiratory illness and recover without specific treatment.older people and those with underlying medical problems like cardiac diseases,diabetes,any chronic respiratory disease and cancer are more likely to have serious illness.the covid 19 virus spreads primarily through droplets of saliva or discharge from the nose oral cavity when an infected person coughs or sneezes.people with covid19 have had a wide range of symptoms reported _ranging from mild to severe symptoms.symptoms may appear 2_14 days after exposure to the infection .any one can have mild to severe symptoms.people with these symptoms may have covid 19: fever or shivering,cough,shortness of breath,fatigue,body or muscle aches,headache,new loss of smell or taste ,sore thraot,congestion or running nose , nausea or vomiting,diarrhoea. The most common hematological clinical findings include lymphocytopenia,neutrophilia,eosinophilia,mild thrombocytopenia,and less frequently thrombocytosis,the presence of reactive lymphocytes has been reported only occasionally the leucocyte count may be normal,reduced or increased.according to a meta analysis leucocytosis,lymphopenia and thrombocytopenia are associated with greater severity and fatality in covid 19 cases

Registry
clinicaltrials.gov
Start Date
January 2022
End Date
April 2023
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Radwa mahmoud elsayed

Dr/Radwa mahmoud elsayed

Assiut University

Eligibility Criteria

Inclusion Criteria

  • all covid 19 patients diagnosed by pcr or CT chest

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Hematological disorders in covid 19 patients

Time Frame: Baseline

to detect hematological abnormalities in covid 19 patients and its correlation to outcome and severity of the disease

Similar Trials